Viet-Khoa Tran-Nguyen, Rajendra Prasad, Pierre Falson* and Ahcene Boumendjel * Pages 3242 - 3253 ( 12 )
Background: The multicomponent primary active ATP-binding cassette transporter Cdr1p in the structure of the pathogenic yeast Candida albicans is among the culprits of antifungal agent resistance reported in recent decades. So far, various potential novel inhibitors/ modulators of this protein have been purified, synthesized, and biologically tested, with results showing their ability to effectively reverse CaCdr1p-mediated drug resistance phenomenon. These compounds are of diverse origins, possess non-identical structural features and adopt different mechanisms of action.
Method: A structured search of chemical features and mechanisms of studied modulators of CaCdr1p was carried out using both original research publications and review articles. The nature of possible inhibitory mechanisms against the pump was analyzed in relation to the structure and the activity of the transporter. A process of summarizing modulatory spectra of the listed compounds against 2 other efflux pumps of Candida albicans namely Cdr2p and Mdr1p was also conducted, during which selective inhibitors of Cdr1p were revealed.
Results: In this article, 6 possible mechanisms with which a molecule can manifest their activity against the efflux pump are described, and a list of nearly 50 CaCdr1p modulators found in literatures along with their respective mechanism(s) (if already identified) is provided, summarizing the results obtained so far in the search of new inhibitors of the drug extrusion transporter that can enhance the potency of commonly used antifungal agents. A table of inhibitory spectra of the listed compounds against Cdr1p, Cdr2p and Mdr1p is also given, with several selective modulators of Cdr1p finally indicated.
Conclusion: The findings of this review contribute to future studies regarding CaCdr1p and its modulators by summarizing the results obtained so far on this emerging issue of health sciences. Further research concerning novel compounds capable of inhibiting Cdr1p needs to be carried out in hopes of completing the lists provided in this article.
Candida albicans, Cdr1p, efflux pump, modulator, inhibitor, mechanism, binding, interaction.
Department of Molecular Pharmacochemistry (DPM), UMR 5063, Grenoble Alpes University, F-38041 Grenoble, School of Life Sciences, Jawaharlal Nehru University, 110067 New Delhi, Drug Resistance and Membrane Proteins, UMR 5086, CNRS/Lyon 1 University, 69367 Lyon, Department of Molecular Pharmacochemistry (DPM), UMR 5063, Grenoble Alpes University, F-38041 Grenoble